儿童医院心理健康住院期间的药物约束使用
OBJECTIVES: Primary mental health admissions are increasing across US children's hospitals. These patients may experience agitation requiring pharmacologic restraint.…
要点
- 药物约束涉及3%的住院和1.3%的患者日。
- 自闭症、物质相关障碍和破坏性障碍的药物约束率最高。
- 破坏性障碍、双相障碍、进食障碍和躯体障碍的约束率显著上升。
核心结论
- 以精神健康诊断为主要入院原因的儿童住院中,药物约束使用发生率增加且因诊断而异。
主要发现
- 3%的住院和1.3%的患者日涉及药物约束。
- 药物约束使用率趋势稳定(95%CI 0.7-2.1),而发生率增加141%。
- 每1000患者日药物约束率最高的诊断包括自闭症(79.4;95%CI 56.2-112.3)、物质相关障碍(45.0;95%CI 35.9-56.4)和破坏性障碍(44.8;95%CI 25.1-79.8)。
- 破坏性障碍(RR 1.4;95%CI 1.1-1.6)、双相障碍(RR 2.0;95%CI 1.4-3.0)、进食障碍(RR 2.4;95%CI 1.5-3.9)和躯体障碍(RR 4.2;95%CI 1.9-9.1)的约束率显著增加。
- 自闭症(RR 0.8;95%CI 0.6-1.0)和焦虑障碍(RR 0.3;95%CI 0.2-0.6)的约束率显著下降。
临床怎么用
- 临床可依据诊断特征识别药物约束高风险患者,并针对高约束率诊断制定干预措施以优化药物约束使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Primary mental health admissions are increasing across US children's hospitals. These patients may experience agitation requiring pharmacologic restraint. This study characterized pharmacologic restraint use in medical inpatient units by primary mental health diagnosis. METHODS: This retrospective, cross-sectional study used the Pediatric Health Information System database. The study included children aged 5 to 17 years admitted with a primary mental health diagnosis between 2016 and 2021. Rates of pharmacologic restraint use per 1000 patient days were determined for 13 mental health diagnoses and trended over time with Poisson regression. RESULTS: Of 91 898 hospitalizations across 43 hospitals, 3% of admissions and 1.3% of patient days involved pharmacologic restraint. Trends in the rate of pharmacologic restraint use remained stable (95% confidence interval [CI], 0.7-2.1), whereas the incidence increased by 141%. Diagnoses with the highest rates of pharmacologic restraint days per 1000 patient days included autism (79.4; 95% CI, 56.2-112.3), substance-related disorders (45.0; 95% CI, 35.9-56.4), and disruptive disorders (44.8; 95% CI, 25.1-79.8). The restraint rate significantly increased in disruptive disorders (rate ratio [RR], 1.4; 95% CI, 1.1-1.6), bipolar disorders (RR, 2.0; 95% CI, 1.4-3.0), eating disorders (RR, 2.4; 95% CI, 1.5-3.9), and somatic disorders (RR, 4.2; 95% CI, 1.9-9.1). The rate significantly decreased for autism (RR, 0.8; 95% CI, 0.6-1.0) and anxiety disorders (RR, 0.3; 95% CI, 0.2-0.6). CONCLUSIONS: Pharmacologic restraint use among children hospitalized with a primary mental health diagnosis increased in incidence and varied by diagnosis. Characterizing restraint rates and trends by diagnosis may help identify at-risk patients and guide targeted interventions to improve pharmacologic restraint utilization.
引用
- Masserano B, Hall M, Wolf R, et al. Pharmacologic Restraint Use During Mental Health Admissions to Children's Hospitals. Pediatrics. 2024. PMID: 38073316. doi:10.1542/peds.2023-062784
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。